Vigilant: Suffer from second liver to must not change cure!

Hong Kong big college of medicine considers to discover, two into the lymphatic tumour patient that has recessive hepatitis B, accepting after changing cure, appear more easily the disease related hepatitis B, cite the exhaustion that send liver even and die. They suggest, cancer patient is being accepted before changing cure, should undertake gene of more accurate second liver virus checks, in order to decide oneself whether " carrier " . This research is learned to be fastened in by internal medicine of college of medicine of Li Jiacheng of Hong Kong university 1998 to undertake between 2005, study 244 are accepting the lymphatic tumour patient that turns cure in all, there are 57 people in the center, make an appointment with namely two becoming is " carrier of recessive hepatitis B " , conventional albumen test also fails check goes out, must pass through detect the catenary of real time polymerization of gene of hepatitis B virus locks up reaction (abbreviation PCR) , ability decides they are hepatitis B carrier. This 57 people are being accepted after changing cure, among them 8 people cause the disease related hepatitis B, 3 people fail because of liver in the center and die. The science inside college of medicine of Hong Kong university fastens associate professor Xu Zhijian to point out, at present Hong Kong has 700 thousand person is hepatitis B carrier, additionally about two is become is " recessive " carrier and oneself do not know. Harbor big internal medicine learns to fasten a lecture to teach explanation of Liang Xian grandson to say, change cure or steroid cure to be able to make drop to force of human body immunity, hepatitis B virus fails to suffer restrain, make the disease of hepatitis B appears more easily or have a relapse, liver fails and die even. Xu Zhijian points out, traditional albumen test fails to find out hepatitis B carrier completely, albumen test examines hepatitis B is an antiquated concept, the method of PCR is relatively accurate; actually patient of more than and lymphatic tumour, all need are accepted change cure, do not tell the cancer patient that oneself are hepatitis B carrier again, accepting after changing cure, suffer from more easily on the disease related hepatitis B, bring about liver to fail even and die. Xu Zhijian suggests the patient is accepted before changing cure, should accept PCR to detect, affirmatory whether hepatitis B carrier, "Doctor also patient of should close censorial hepatitis B is accepting the case after changing cure, if discover relevant disease, should inflict of as soon as possible is treated " . He says, current, private assay place and public hospital can have Hong Kong share PCR checks. It is reported, this research is first research discovery patient of recessive second liver and accept turn the concern between cure, research was published in July 2006 as a result periodical learns in international cure " Gastroenterology " . (the exercitation edits: Plum apricot)